• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Align Technology Hasn't Lost Its Smile

ALGN made a bearish key reversal Thursday but there is no follow-through selling.
By BRUCE KAMICH
Apr 30, 2021 | 11:02 AM EDT
Stocks quotes in this article: ALGN

For his final "Executive Decision" segment of Mad Money Thursday night, Jim Cramer checked in Joe Hogan, president and CEO of Align Technology (ALGN) , the orthodontics supplier.

ALGN just posted 62% revenue growth with better-than-expected earnings. The shares, however, fell 1.4%, a move Cramer called a mistake.

Hogan said digital orthodontics have been a game changer for the industry. He said nearly 75% of all adults have an alignment issue that could be rectified by Align.

Align has been a life-saver for many dental offices, Hogan noted. As patients dwindled during the pandemic, Align's products were able to augment declining revenues.

Align is investing heavily into research and development, Hogan said. The company uses artificial intelligence algorithms to help determine the best way to move teeth to where they need to go and the company is also offering remote monitoring services to help patients avoid some trips to the dentist's office.

We looked at the charts of ALGN just last week and wrote that "The charts and indicators of ALGN are bullish. Traders can continue to hold prior longs and new longs or additional longs could be bought at current levels. A $570 stop is recommended. The round number of $700 and then the Point and Figure target of $821 are our price targets."

Let's check out the charts again to see if there might be a reversal happening.

In the daily bar chart of ALGN, below, we can see that the shares made a key reversal day on Thursday -- prices made a new high for the move up but closed significantly lower. The slopes of the 50-day moving average line and the 200-day moving average line are still positive.

The On-Balance-Volume (OBV) line shows a slight turn to the downside indicating that sellers of ALGN are more aggressive. This might be a one and done event or the start of a new trend. The Moving Average Convergence Divergence (MACD) oscillator has narrowed but it has not yet crossed to the downside.

In the weekly Japanese candlestick chart of ALGN, below, we can see a large upper shadow as traders rejected the new highs Thursday. The slope of the 40-week moving average line is still very positive.

The OBV line has been weakening for the past four months. The MACD oscillator is pointed down but has been narrowing towards a new buy signal.

In this daily Point and Figure chart of ALGN, below, we can see a potential upside price target in the $821 area. A trade at $584.08 would be a new low for the move down and is likely to weaken the chart should it develop.

In this weekly Point and Figure chart of ALGN, below, we can see a potential longer-term price target in the $943 area.

Bottom-line strategy: ALGN made a bearish key reversal Thursday but there is no follow-through selling. If Thursday's price action kick started a downtrend it would be bearish but it has not happened thus far. Traders who are long ALGN from earlier recommendations should continue to hold those positions with our suggestion of a stop loss at $570. The $821 area is our price objective.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Earnings | Investing | Stocks | Technical Analysis | Health Care Equipment & Services | Personal Products | Mad Money | Executive Interview

More from Stocks

3 High-Yield Retail Stocks With Attractive Valuations

Bob Ciura
May 27, 2022 1:30 PM EDT

Here's the bull case for three retail stocks that offer low valuations and high dividend yields.

Here's How to Wrangle JPMorgan, the '800-Pound Gorilla' of Banking

Brad Ginesin
May 27, 2022 1:27 PM EDT

The financial services giant just held its first investor day in three years -- let's open the vault and see what's inside.

As Zscaler Rallies, Charts Say the Stock Could Hit This Level Soon

Bruce Kamich
May 27, 2022 1:23 PM EDT

Here's how aggressive traders can play the cybersecurity name.

From Wall Street to Fantasy Island

Jim Collins
May 27, 2022 12:25 PM EDT

So, let me get this straight -- costs are rising, units are declining, and yet earnings are going to grow? Yeah, right.

Big Lots: Big Drop and Bearish

Bruce Kamich
May 27, 2022 12:15 PM EDT

The shares are sharply lower after its latest quarterly results.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 10:58 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "The Tremendous Power of the Sell Button"
  • 02:46 PM EDT STEPHEN GUILFOYLE

    We're Shedding Some of This Holding on Strength

    Check out the Stocks Under $10 portfolio here!
  • 11:33 AM EDT PETER TCHIR

    Thoughts Ahead of the Fed Minutes

    Recent economic and earnings issues are convincing...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login